Author

K. M. Prise

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

C. W. D. Armstrong· 1 shared C. W. Ong· 1 shared D. J. J. Waugh· 1 shared I. G. Mills· 1 shared J. A. Coulter· 1 shared J. M. O'Sullivan· 1 shared K. T. Butterworth· 1 shared M. J. LaBonte· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. W. D. Armstrong

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma

C. W. D. Armstrong, J. A. Coulter, C. W. Ong, P. J. Maxwell, S. Walker, K. T. Butterworth, O. Lyubomska, S. Berlingeri, R. Gallagher, J. M. O'Sullivan, S. Jain, I. G. Mills, K. M. Prise, R. G. Bristow, M. J. LaBonte, D. J. J. Waugh

This study identifies PTEN-deficiency-associated CXC-chemokine signaling as a driver of radiotherapy resistance in prostate cancer and shows that targeting CXCR1/2 improves radiotherapy outcomes.

bioRxiv · Mar 16, 2020 · PreprintCancer Biology